RIGL

RIGL Change in Working Capital

-$11.51MTTM · USD

Period ending:

RIGL FY Change in Working CapitalUSD
RIGL FY Change in Working Capital1999-12-31: $931.00K2000-12-31: -$1.22M2001-12-31: $1.57M2002-12-31: -$3.15M2003-12-31: $4.66M2004-12-31: $13.26M2005-12-31: $11.03M2006-12-31: -$12.20M2007-12-31: $9.03M2008-12-31: $3.64M2009-12-31: -$6.07M2010-12-31: -$8.90M2011-12-31: $1.48M2012-12-31: -$1.40M2013-12-31: -$6.79M2014-12-31: -$195.00K2015-12-31: $19.27M2016-12-31: -$15.79M2017-12-31: -$5.43M2018-12-31: $4.12M2019-12-31: $16.66M2020-12-31: -$30.32M2021-12-31: $9.72M2022-12-31: -$29.05M2023-12-31: $9.52M2024-12-31: $153.00K2025-12-31: -$19.51M$19.27M-$30.32M
1999-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RIGL change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.

Rigel Pharmaceuticals Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-19,512,000
153,000
9,517,000
-29,049,000
9,718,000
-30,322,000
16,659,000
4,122,000
-5,430,000
-15,792,000
19,266,000
-195,000
-6,792,000
-1,402,000
1,475,000
-8,900,000
-6,073,000
3,644,000
9,034,000
-12,196,000
11,026,000
13,261,000
4,663,000
-3,146,000
1,574,000
-1,215,000
931,000

Compare change in working capital

All RIGL financial metrics · RIGL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.